Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases

被引:8
作者
Kashiwabara, K [1 ]
Nakamura, H [1 ]
Kiguchi, T [1 ]
Matsuoka, T [1 ]
机构
[1] Tokyo Med Coll, Dept Internal Med 5, Ami, Ibaraki 30003, Japan
关键词
tumor marker; non-insulin-dependent diabetes mellitus; liver cirrhosis; hemodialysis; aspartate aminotransferase; alanine aminotransferase;
D O I
10.1016/S0009-8981(98)00026-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
It has been reported that cytokeratin 19 fragment (CYFRA 21-1) is superior to tissue polypeptide antigen (TPA) as a tumor marker, although there is a high correlation between CYFRA 21-1 and TPA levels in patients with lung cancer. We investigated correlations between these tumor markers in patients with non-malignant diseases. Marked correlations were found between CYFRA 21-1 and TPA levels in healthy subjects (n = 31), non-insulin-dependent diabetes mellitus (n = 160) and hemodialysis patients (n = 83) (range of r-value = 0.90-0.93, P < 0.0001). However in liver cirrhosis patients (n = 36), only a weak correlation was found (r=0.39, P < 0.0001) and there were correlations between only TPA and both aspartate aminotransferase and alanine aminotransferase levels (r(2) = 0.48 and 0.36, P < 0.0001). The elevated TPA levels in liver cirrhosis patients may be related to the decreased specificity of TPA as a tumor marker. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 18 条
  • [11] CLINICAL-EVALUATION OF 7 TUMOR-MARKERS IN LUNG-CANCER DIAGNOSIS - CAN ANY COMBINATION IMPROVE THE RESULTS
    PLEBANI, M
    BASSO, D
    NAVAGLIA, F
    DEPAOLI, M
    TOMMASINI, A
    CIPRIANI, A
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (01) : 170 - 173
  • [12] CYFRA-21-1, A SENSITIVE AND SPECIFIC NEW TUMOR-MARKER FOR SQUAMOUS-CELL LUNG-CANCER - REPORT OF THE FIRST EUROPEAN MULTICENTER EVALUATION
    RASTEL, D
    RAMAIOLI, A
    CORNILLIE, F
    THIRION, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 601 - 606
  • [13] Sarwar M, 1994, Ann Nucl Med, V8, P301
  • [14] STIEBER P, 1993, EUR J CLIN CHEM CLIN, V31, P689
  • [15] Stieber Petra, 1994, International Journal of Biological Markers, V9, P82
  • [16] DISEASE MONITORING BY THE TUMOR-MARKERS CYFRA-21.1 AND TPA IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    VANDERGAAST, A
    KOK, TC
    KHO, GS
    BLIJENBERG, BG
    SPLINTER, TAW
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1790 - 1793
  • [17] EVALUATION OF A NEW TUMOR-MARKER IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER - CYFRA-21.1
    VANDERGAAST, A
    SCHOENMAKERS, CHH
    KOK, TC
    BLIJENBERG, BG
    CORNILLIE, F
    SPLINTER, TAW
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (03) : 525 - 528
  • [18] TISSUE POLYPEPTIDE ANTIGEN (TPA) IS RELATED TO THE NON-EPIDERMAL KERATIN-8, KERATIN-18 AND KERATIN-19 TYPICAL OF SIMPLE AND NON-SQUAMOUS EPITHELIA - RE-EVALUATION OF A HUMAN-TUMOR MARKER
    WEBER, K
    OSBORN, M
    MOLL, R
    WIKLUND, B
    LUNING, B
    [J]. EMBO JOURNAL, 1984, 3 (11) : 2707 - 2714